SFA — Sopharma AD Cashflow Statement
0.000.00%
Last trade - 00:00- €1.78bn
- €2.05bn
- €1.35bn
Annual cashflow statement for Sopharma AD, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | fx Final |
| Changes in Working Capital | -75.6 | -74.1 | -87 | -105 | -129 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -38.8 | 56.3 | 23 | 39.2 | 9.48 |
| Capital Expenditures | -13.9 | -12.1 | -22.1 | -62.1 | -73 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -20.9 | -20.4 | -10 | 17 | 11.3 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -34.8 | -32.5 | -32.1 | -45 | -61.7 |
| Financing Cash Flow Items | 104 | 15.6 | -0.262 | 2.48 | 30.2 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 80.1 | -32.9 | 64.9 | -41.9 | 70.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.43 | -9.13 | 55.7 | -47.7 | 18.4 |